Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.

Neuropharmacology

Department of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, USA. Electronic address:

Published: November 2019

AI Article Synopsis

  • - This study investigates how the medial habenula-interpeduncular nucleus (MHb-IPN) pathway affects negative feelings during nicotine withdrawal, focusing on potential differences between males and females.
  • - Researchers measured acetylcholine levels and gene expression of nicotinic acetylcholine receptor subunits in the interpeduncular nucleus of both female and male rats following 14 days of nicotine treatment and subsequent withdrawal.
  • - Findings revealed that female rats showed higher acetylcholine levels and more anxiety-like behaviors than males after withdrawal, with specific changes in gene expression linked to the observed behaviors, highlighting sex differences in the cholinergic system's role during nicotine withdrawal.

Article Abstract

The medial habenula-interpeduncular nucleus (MHb-IPN) pathway modulates negative affective states produced by nicotine withdrawal. Sex differences in the contribution of acetylcholine (ACh) systems in this pathway have not been explored. Thus, this study assessed ACh levels and gene expression of α- and β-containing nicotinic acetylcholine receptor (nAChR) subunits in the IPN of female and male rats following nicotine treatment and withdrawal. Rats were prepared with a pump that delivered nicotine for 14 days, and naïve controls received a sham surgery. In Study 1, rats were prepared with a probe in the IPN, and ACh levels were measured following saline and then mecamylamine administration. In Study 2, separate groups of naïve control or nicotine-treated rats received saline or mecamylamine and physical signs and anxiety-like behavior were assessed using elevated plus maze (EPM) procedures. The IPN was then dissected and mRNA levels were assessed using RT-qPCR methods. Nicotine treatment increased ACh levels to a larger extent in females than males. Nicotine withdrawal produced a similar increase in physical signs; however, females displayed greater anxiety-like behavior than males. In females, gene expression of α5 increased following nicotine treatment and withdrawal. In males, α7 increased following nicotine treatment and α2 and α3 increased during nicotine withdrawal. Both females and males displayed an increase in β3 and β4 during nicotine withdrawal. In females, anxiety-like behavior was correlated with α4, α5, and β2 gene expression in the IPN. These results suggest that sex differences in withdrawal are modulated via cholinergic systems in the IPN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752203PMC
http://dx.doi.org/10.1016/j.neuropharm.2019.107714DOI Listing

Publication Analysis

Top Keywords

nicotine withdrawal
16
nicotine treatment
16
sex differences
12
ach levels
12
gene expression
12
anxiety-like behavior
12
increased nicotine
12
nicotine
10
cholinergic systems
8
withdrawal
8

Similar Publications

Incentives for smoking cessation.

Cochrane Database Syst Rev

January 2025

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Background: Financial incentives (money, vouchers, or self-deposits) can be used to positively reinforce smoking cessation. They may be used as one-off rewards, or in various schedules to reward steps towards sustained smoking abstinence (known as contingency management). They have been used in workplaces, clinics, hospitals, and community settings, and to target particular populations.

View Article and Find Full Text PDF

Tobacco use is the leading cause of death globally and in the U.S. After decades of decline, driven by decreases in combusted tobacco use, nicotine product use has increased due to Electronic Nicotine Delivery Systems (ENDS), also known as e-cigarettes or vapes.

View Article and Find Full Text PDF

Despite progress in smoking reduction in the past several decades, cigarette smoking remains a significant public health concern world-wide, with many smokers attempting but ultimately failing to maintain abstinence. However, little is known about how decision-making evolves in quitting smokers. Based on preregistered hypotheses and analysis plan ( https://osf.

View Article and Find Full Text PDF

Background: Smoking negatively impacts postoperative outcomes but acute abstinence from smoking during hospitalization can increase postoperative pain, lower pain thresholds, disrupt pain management, and trigger hyperalgesia due to abrupt nicotine withdrawal in tobacco users. Nicotine replacement therapy has been recommended to minimize these complications. We hypothesized that a high dose (21 mg/24 h) transdermal nicotine (TDN) patch would reduce postoperative pain and opioid requirements.

View Article and Find Full Text PDF

People with HIV (PWH) smoke cigarettes at triple the rate of the general population in the US. Efforts to increase quit rates in this group have met with limited success. The nicotine metabolite ratio (NMR) has shown promise as a phenotypic marker that may be useful in selecting the most appropriate cessation treatments for people who smoke cigarettes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!